Daiwa Securities Group Inc. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 111 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$04030.0%0.00%
Q2 2023$04030.0%0.00%
Q1 2023$04030.0%0.00%
Q4 2022$0
-100.0%
4030.0%0.00%
Q3 2022$1,0004030.0%0.00%
Q2 2022$04030.0%0.00%
Q1 2022$04030.0%0.00%
Q4 2021$0
-100.0%
4030.0%0.00%
Q3 2021$1,0000.0%4030.0%0.00%
Q2 2021$1,0000.0%4030.0%0.00%
Q1 2021$1,0000.0%4030.0%0.00%
Q4 2020$1,0004030.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$38,182,0007.99%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 10,406,850$26,225,0004.02%
MILLER VALUE PARTNERS, LLC 12,385,586$31,211,0001.12%
CHIRON CAPITAL MANAGEMENT, LLC 201,470$508,0000.41%
Sargent Investment Group, LLC 289,025$728,0000.26%
MAGNOLIA CAPITAL ADVISORS LLC 80,542$404,0000.16%
XTX MARKETS LLC 11,086$28,0000.14%
Virtus ETF Advisers LLC 99,108$250,0000.13%
Old West Investment Management, LLC 210,226$529,0000.12%
EQUITEC PROPRIETARY MARKETS, LLC 31,300$79,0000.06%
View complete list of ZIOPHARM ONCOLOGY INC shareholders